On 17 September, Leadsynbio participated simultaneously in Vitafoods Asia 2025 in Bangkok, Thailand, and WPE&WHPE 2025 in Xi’an, China, presenting its flagship synthetic biology-based products and forward-looking solutions. Both exhibitions attracted a broad audience of buyers, experts, and partners, offering a dynamic platform for exchanges and collaboration.

At these two events, Leadsynbio showcased its leading human nutrition portfolio, with a particular focus on the NMN and NAD nicotinamide nucleotide series. Backed by technological breakthroughs and end-to-end supply chain strengths, the company has achieved large-scale production and reliable delivery of anti-aging ingredients such as NMN and NAD. 

To meet evolving market needs, Leadsynbio has also expanded into a broad pipeline of offerings addressing areas such as healthy aging, mood support, weight management, and eye health—aiming to provide global customers with bio-manufactured ingredients that are both sustainable and cost-effective. 

Looking ahead, Leadsynbio will remain focused on advancing and scaling synthetic biotechnology, accelerating the commercialization of new products, and deepening collaboration with peers. Through these efforts, we are dedicated to set new benchmarks in health ingredients and strengthen the growth of the global wellness industry.